We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
51
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$72.2M 0.46%
492,483
+109,264
+29% +$17M
MCD icon
52
McDonald's
MCD
$192B
$68.2M 0.44%
254,450
+4,470
+2% +$1.13M
AWK icon
53
American Water Works
AWK
$26.3B
$67.1M 0.43%
355,028
-651
-0.2% -$114K
TXN icon
54
Texas Instruments
TXN
$255B
$66M 0.42%
350,210
+53,603
+18% +$10.3M
MS icon
55
Morgan Stanley
MS
$337B
$63.1M 0.4%
642,679
+164,503
+34% +$16.4M
COST icon
56
Costco
COST
$422B
$62.7M 0.4%
110,403
+6,741
+7% +$3.45M
EMR icon
57
Emerson Electric
EMR
$83.6B
$62.4M 0.4%
671,563
+6,757
+1% +$636K
AZN icon
58
AstraZeneca
AZN
$263B
$61.8M 0.39%
530,605
+16,388
+3% +$1.93M
ANSS
59
DELISTED
Ansys
ANSS
$61.8M 0.39%
153,989
-3,273
-2% -$1.26M
BNTX icon
60
BioNTech
BNTX
$23B
$61.6M 0.39%
240,902
+127,705
+113% +$35M
INTU icon
61
Intuit
INTU
$83.1B
$61.4M 0.39%
95,379
+17,126
+22% +$10.6M
LOW icon
62
Lowe's Companies
LOW
$119B
$60.3M 0.39%
233,474
-26,507
-10% -$6.3M
KO icon
63
Coca-Cola
KO
$362B
$59.1M 0.38%
998,903
+31,575
+3% +$1.76M
SYK icon
64
Stryker
SYK
$129B
$58.8M 0.38%
219,704
+14,379
+7% +$3.77M
WMS icon
65
Advanced Drainage Systems
WMS
$11B
$57.6M 0.37%
423,178
+19,056
+5% +$2.34M
INCY icon
66
Incyte
INCY
$23.7B
$56.8M 0.36%
774,442
+31,702
+4% +$2.14M
BKNG icon
67
Booking.com
BKNG
$145B
$55.7M 0.36%
580,575
+40,925
+8% +$3.88M
SCHW
68
Charles Schwab
SCHW
$181B
$54.6M 0.35%
649,060
-30,534
-4% -$2.47M
EXEL icon
69
Exelixis
EXEL
$14B
$54.3M 0.35%
2,652,814
-85,989
-3% -$1.65M
PTC icon
70
PTC
PTC
$14.5B
$54M 0.34%
445,671
+6,227
+1% +$750K
ADI icon
71
Analog Devices
ADI
$181B
$52.6M 0.34%
299,461
+38,074
+15% +$6.75M
BIIB icon
72
Biogen
BIIB
$29.5B
$52.3M 0.33%
217,877
-54,766
-20% -$14.1M
OC icon
73
Owens Corning
OC
$11.6B
$51.8M 0.33%
572,194
-19,537
-3% -$1.77M
IQV icon
74
IQVIA
IQV
$35.6B
$50.9M 0.33%
180,485
-30,738
-15% -$7.98M
ISRG icon
75
Intuitive Surgical
ISRG
$128B
$50.8M 0.32%
141,305
+4,151
+3% +$1.43M
1 2
3
4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.